The Archive · 3 posts
Revolutionise kidney health with Renalytix (RENX)! 🌟 Innovating diagnostics to fight kidney disease. Join the healthcare revolution on LSE! 🏥
Renalytix raises FY26 revenue target 33% to $4M, announces major hospital pilot with 40,000+ CKD patient reach for FDA-approved kidney test.
February 11, 2026
Showing 2 of 3 posts
Renalytix partners with Tempus AI to scale its FDA-approved, Medicare-reimbursed kidney disease test across 15M eligible US patients. Strategic expansion for early intervention.
JoshuaSeptember 15, 2025
Renalytix achieves 20% Q3 revenue growth & 1,000 billable tests milestone with FDA-approved kidneyintelX.dkd, backed by Medicare. Expansion continues with new payors & networks.
JoshuaApril 10, 2025